European life sciences investor LSP has launched the €150m (US$183.1m) LSP Dementia Fund. It will be managed by dementia scientist and thought leader Philip Scheltens. A first of its kind, the LSP Dementia Fund will focus on all stages of dementia drug and medtech development. Its aim to find novel treatments to battle the different…
©2021 All rights reserved LaingBuisson 
 LSP Dementia Fund.){kind=link}